Akari Therapeutics Plc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $34.1m $28.1m $5.4m $5.7m $7.8m $9.4m $13.2m $3.8m $2.6m $0
Prepaid Expense and Other Assets, Current $1.5m $706k $1.4m $713k $1.8m
Short-term Investments $10.0m $0
Prepaid expenses $293k $2.2m $465k
Other current assets $229k $90k $100k
Assets, Current $45.6m $28.8m $7.5m $6.8m $9.7m $11.6m $13.8m $4.3m $3.0m $5.5m
Total current assets $45.6m $28.8m $7.5m $6.8m $13.7m $11.6m $13.8m
Property, Plant and Equipment, Net $58k $56k $20k $5k $2k $0 $0
Goodwill $8.4m $8.4m
Intangible Assets, Net (Excluding Goodwill) $39k $39k $33k $30k $28k $23k $17k $14k
Additional Financial Items
Patent acquisition costs, net $39k $39k $33k $30k $27k $23k $17k
Warrant liability $0 $7.9m
Other liability $0 $94k
Liability related to deposits received for share subscriptions $0 $1.1m $0
Share capital of $0.0001 par value Authorized: 15,000,000,000 ordinary shares; issued and outstanding: 7,444,917,123 and 4,759,731,923 at December 31, 2022 and December 31, 2021, respectively 18.3m 22.9m 23.7m 32.0m 46.6m 476k 744k
Capital redemption reserve $0 $52.2m $52.2m $52.2m
Accrued Liabilities, Current $1.8m $4.8m $1.5m $4.2m $2.6m $3.2m $3.1m $1.6m $3.1m $2.3m
Total shareholders' equity $34.1m $17.2m $3.1m ($1.8m) $6.9m $5.6m $1.8m
Assets $45.9m $29.1m $8.0m $6.8m $9.7m $11.6m $13.8m $4.4m $50.6m $47.9m
LIABILITIES AND EQUITY
Current liabilities:
Accounts Payable, Current $2.2m $2.0m $1.6m $1.2m $966k $1.8m $947k $1.7m $12.4m $8.8m
Liabilities, Current $11.7m $11.8m $4.9m $19.9m $12.4m
Deferred Income Tax Liabilities, Net $8.0m $7.0m
Other Liabilities, Noncurrent $383k $31k
Deferred Tax Liabilities, Net $8.0m $7.0m
Liabilities $11.8m $11.9m $4.9m $8.6m $6.4m $6.1m $12.0m $4.6m $28.3m $19.6m
Stockholders’ equity:
Common Stock, Value, Issued $18.3m $22.9m $23.7m $32.0m $40.1m $476k $744k $1.3m $5.3m
Additional Paid in Capital $91.0m $104.8m $106.6m $110.5m $136.5m $153.1m $167.1m $174.8m $212.7m $234.3m
Retained Earnings (Accumulated Deficit) ($74.9m) ($110.3m) ($126.8m) ($143.9m) ($168.9m) ($199.7m) ($217.5m) ($227.5m) ($247.3m) ($264.6m)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($280k) ($236k) ($352k) ($349k) ($572k) ($541k) ($771k) ($1.0m) ($738k) ($782k)
Accumulated other comprehensive loss ($280k) ($236k) ($352k) ($349k) ($621k) ($541k) ($771k)
Stockholders' Equity Attributable to Parent $34.1m $17.2m $3.1m ($1.8m) $3.3m $5.6m $1.8m ($229k) $22.2m $28.3m
Liabilities and Equity $45.9m $29.1m $8.0m $6.8m $9.7m $11.6m $13.8m $4.4m $50.6m $47.9m
Total liabilities and shareholders' equity $45.9m $29.1m $8.0m $6.8m $13.7m $11.6m $13.8m